APC and neoplasm: In the early 1990s, the generation of genetically engineered mouse models (GEMMs) bearing nonsense mutations in the Apc gene that develop spontaneously multiple intestinal neoplasias similar to the FAP patients [36] has contributed enormously to the understanding of the molecular pathways involved in the early stages of tumor development.